🔗 Share this article

While the US proceeds with sweeping adjustments to its vaccination schedules, one figure appears in a surprising turn: Tracy Beth Høeg, a US-based physician and epidemiologist who initially gained attention by casting doubt on Covid vaccinations throughout the pandemic and has zeroed in on possible fatalities following Covid immunization in her brief time at the Food and Drug Administration.

Proposed Changes to Childhood Immunization Program

Public health authorities were set to announce sweeping revisions to the childhood immunization program earlier this month, bringing the US with the Danish immunization schedule, sources say – a major change that would put the US at odds with many the global community with no evidence for benefit. The announcement has been pushed back until the next year.

In place of the top vaccines chief, Dr. Høeg is scheduled to address the audience at the event. She was recently named interim head of the FDA’s Center for Drug Evaluation and Research (CDER), the fifth appointee to head the division this year.

A Shift at the Agency

The acting appointment could signify a tighter collaboration between the pharmaceutical and biologics centers as Høeg and Prasad consolidate power at the FDA – and it signals a increased emphasis upon dismantling already-approved immunizations at the FDA.

Høeg has repeatedly called for halting specific childhood shot schedules in the US in order to be more in line with Denmark's approach, a society with nationalized medicine and a number of inhabitants roughly the size of the state of Wisconsin.

So far public appearances, she has kept her attention on immunizations – typically the purview of Prasad, head of the FDA’s Center for Biologics Evaluation and Research (CBER) – rather than drug regulation.

Questions Over Expertise

The appointee has no apparent experience in drug development, oversight or management, which has been standard for past heads of the biologics center. She has served at the FDA as a key advisor to the commissioner and the vaccine center since earlier this year.

“She doesn’t seem to have any of the qualifications” for running the drug-regulation department, said Dr. Jonathan Howard. “She lacks experience running a randomized controlled trial. She lacks experience in running a major agency. She lacks background in industry regulation.”

Previous commissioners of CBER would “be deeply familiar with legal statutes and the research of medication creation”, noted Janet Woodcock. “Objectively, she doesn’t have the sort of resume that former directors who led CBER have had.”

The drug center has an enormous range of responsibilities at the FDA, Woodcock stated.

“The public just zeroes in on the novel medication approvals, but the generic drug division authorizes a multitude of generic drugs. There is also a biologic copycat branch, over-the-counter program and so forth, and every single one have to be managed,” she said. “The area you overlook, that’s the thing that I always told people is going to come back to haunt you.”

Additionally, a substantial management aspect to the position, which supervises over 5,000 personnel. “It is a huge management job, if you do it right,” Woodcock concluded.

Official Statement and Contentious Policies

Regarding questions about Høeg’s qualifications and whether this selection signifies more teamwork among regulatory chiefs on vaccines, a spokesperson said that the “inquiries are based on flawed assumptions”.

“This background aligns with the responsibilities of her job,” the representative said, citing the time Dr. Høeg spent counseling the agency head on “medication safety and approval science, including computerized risk analysis and shot safety tracking”.

In her interim role, Dr. Høeg inherits the agency head's new expedited review system, a controversial expedited therapy clearance system that apparently concerned her predecessors. “By what process are these therapies being chosen for this voucher program? Who is making the decisions?” Dr. Howard said. “There’s a lot of confidentiality happening at the FDA right now.”

Overall, he remarked, “the Food and Drug Administration looks to be trending towards less stringent regulations of all drugs, except for shots.”

Established History on Immunizations

Regarding vaccines, Dr. Høeg has a more established, if concerning, track record, critics have noted. She authored a research paper using unconfirmed crowd-sourced reports to determine the frequency of heart inflammation following COVID-19 vaccination. She counseled the state of Florida chief medical officer Dr. Joseph Ladapo, who reportedly have changed statistics to suggest Covid vaccinations are more dangerous than they are.

Among her “policy goals” for the incoming administration included changing regulations for recently developed shots and discontinuing “non-essential” immunizations, she remarked after the election on a online show. At the agency, Høeg has according to sources proposed excluding teenage boys from receiving Covid vaccines.

“She’s an all-around true believer who starts off with her preconceived notions and works backwards to accommodate the science in a highly misleading, dishonest way,” Dr. Howard argued.

Consolidating Power and a “Campaign of Retribution”

Dr. Høeg became part of fellow dissenters, {like|